{"id":8611,"date":"2021-04-02T09:50:00","date_gmt":"2021-04-02T16:50:00","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=8611"},"modified":"2021-04-06T09:50:42","modified_gmt":"2021-04-06T16:50:42","slug":"the-neutralization-potency-of-anti-sars-cov-2-therapeutic-human-monoclonal-antibodies-is-retained-against-novel-viral-variants","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/04\/02\/the-neutralization-potency-of-anti-sars-cov-2-therapeutic-human-monoclonal-antibodies-is-retained-against-novel-viral-variants\/","title":{"rendered":"The Neutralization Potency of Anti-SARS-CoV-2 Therapeutic Human Monoclonal Antibodies Is Retained against Novel Viral Variants"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><i><span style=\"font-weight: 400\">[Pre-print, not peer-reviewed]<\/span><\/i><span style=\"font-weight: 400\"> Neutralizing activity of four experimental monoclonal antibodies (mAbs) (MD65, MD62, MD29 and BL6) targeting the receptor-binding domain (RBD) of SARS-CoV-2 were largely retained against a panel of the top 10 RBD mutations including mutations found in several variants of concern.<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Rosenfeld et al.\u00a0(Apr 1, 2021). The Neutralization Potency of Anti-SARS-CoV-2 Therapeutic Human Monoclonal Antibodies Is Retained against Novel Viral Variants. Pre-print downloaded Apr 2 from <\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2021.04.01.438035\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1101\/2021.04.01.438035<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[Pre-print, not peer-reviewed] Neutralizing activity of four experimental monoclonal antibodies (mAbs) (MD65, MD62, MD29 and BL6) targeting the receptor-binding domain (RBD) of SARS-CoV-2 were largely retained against a panel of the top 10 RBD mutations including mutations found in several variants of concern. Rosenfeld et al.\u00a0(Apr 1, 2021). The Neutralization Potency of Anti-SARS-CoV-2 Therapeutic Human&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/04\/02\/the-neutralization-potency-of-anti-sars-cov-2-therapeutic-human-monoclonal-antibodies-is-retained-against-novel-viral-variants\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[28],"topic":[19],"class_list":["post-8611","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-treatment","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=8611"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8611\/revisions"}],"predecessor-version":[{"id":8612,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8611\/revisions\/8612"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=8611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=8611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=8611"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=8611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}